Osiris Therapeutics (OSIR) Posts Q4 Profit of 11c/Share
Tweet Send to a Friend
Osiris Therapeutics (NASDAQ: OSIR) reported Q4 EPS of $0.11, $0.54 worse ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
